| Report Title | Price | Action |
|---|---|---|
| p38 MAP Kinase (EC 2.7.11.24) - Drugs in Development, 2021
p38 MAP Kinase (EC 2.7.11.24) - Drugs in Development, 2021 Summary p38 MAP Kinase (EC 2.7.11.24) - Drugs in Development, 2021 provides in depth anal...
Published: Apr-2021 | No. of Pages: 50
|
$ 3000 | |
| Sodium/Glucose Cotransporter 1 (High Affinity Sodium-Glucose Cotransporter or Solute Carrier Family 5 Member 1 or SGLT1 or SLC5A1) - Drugs in Development, 2021
Sodium/Glucose Cotransporter 1 (High Affinity Sodium-Glucose Cotransporter or Solute Carrier Family 5 Member 1 or SGLT1 or SLC5A1) - Drugs in Developm...
Published: Apr-2021 | No. of Pages: 40
|
$ 3000 | |
| Mycobacterium tuberculosis Protein Ag85A - Drugs in Development, 2021
Mycobacterium tuberculosis Protein Ag85A - Drugs in Development, 2021 Summary Mycobacterium tuberculosis Protein Ag85A - Drugs in Development, 2021 ...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Surgical Wound Infections (Infectious Disease) - Drugs in Development, 2021
Surgical Wound Infections (Infectious Disease) - Drugs in Development, 2021 Summary Surgical Wound Infections (Infectious Disease) - Drugs in Develo...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 | |
| Edema (Cardiovascular) - Drugs in Development, 2021
Edema (Cardiovascular) - Drugs in Development, 2021 Summary Edema (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Edema pi...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 | |
| Prothrombin (Coagulation Factor II or F2 or EC 3.4.21.5) - Drugs in Development, 2021
Prothrombin (Coagulation Factor II or F2 or EC 3.4.21.5) - Drugs in Development, 2021 Summary Prothrombin (Coagulation Factor II or F2 or EC 3.4.21....
Published: Apr-2021 | No. of Pages: 50
|
$ 3000 | |
| Vasopressin V1a Receptor (AVPR V1a or Antidiuretic Hormone Receptor 1a or Vascular/Hepatic Type Arginine Vasopressin Receptor or AVPR1A) - Drugs in Development, 2021
Vasopressin V1a Receptor (AVPR V1a or Antidiuretic Hormone Receptor 1a or Vascular/Hepatic Type Arginine Vasopressin Receptor or AVPR1A) - Drugs in De...
Published: Apr-2021 | No. of Pages: 40
|
$ 3000 | |
| P27 (Negative Regulatory Factor or Nef) - Drugs in Development, 2021
P27 (Negative Regulatory Factor or Nef) - Drugs in Development, 2021 Summary P27 (Negative Regulatory Factor or Nef) - Drugs in Development, 2021 pr...
Published: Apr-2021 | No. of Pages: 40
|
$ 3000 | |
| Trypanosomiasis (Infectious Disease) - Drugs in Development, 2021
Trypanosomiasis (Infectious Disease) - Drugs in Development, 2021 Summary Trypanosomiasis (Infectious Disease) - Drugs in Development, 2021 provides...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 | |
| Emesis (Vomiting) (Gastrointestinal) - Drugs in Development, 2021
Emesis (Vomiting) (Gastrointestinal) - Drugs in Development, 2021 Summary Emesis (Vomiting) (Gastrointestinal) - Drugs in Development, 2021 provides...
Published: Apr-2021 | No. of Pages: 45
|
$ 2000 | |
| Sodium Channel Protein Type 3 Subunit Alpha (Voltage Gated Sodium Channel Subtype III or Voltage Gated Sodium Channel Subunit Alpha Nav1.3 or SCN3A) - Drugs in Development, 2021
Sodium Channel Protein Type 3 Subunit Alpha (Voltage Gated Sodium Channel Subtype III or Voltage Gated Sodium Channel Subunit Alpha Nav1.3 or SCN3A) -...
Published: Apr-2021 | No. of Pages: 50
|
$ 3000 | |
| 5-Hydroxytryptamine Receptor 2 (5 HT2 Receptor or HTR2) - Drugs in Development, 2021
5-Hydroxytryptamine Receptor 2 (5 HT2 Receptor or HTR2) - Drugs in Development, 2021 Summary 5-Hydroxytryptamine Receptor 2 (5 HT2 Receptor or HTR2)...
Published: Apr-2021 | No. of Pages: 45
|
$ 3000 | |
| Solute Carrier Family 22 Member 12 (Organic Anion Transporter 4 Like Protein or Renal Specific Transporter or RST or Urate Anion Exchanger 1 or SLC22A12) - Drugs in Development, 2021
Solute Carrier Family 22 Member 12 (Organic Anion Transporter 4 Like Protein or Renal Specific Transporter or RST or Urate Anion Exchanger 1 or SLC22A...
Published: Apr-2021 | No. of Pages: 45
|
$ 3000 | |
| Non-Proliferative Diabetic Retinopathy (NPDR) (Metabolic Disorders) - Drugs in Development, 2021
Non-Proliferative Diabetic Retinopathy (NPDR) (Metabolic Disorders) - Drugs in Development, 2021 Summary Non-Proliferative Diabetic Retinopathy (NPD...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 | |
| Emphysema (Respiratory) - Drugs in Development, 2021
Emphysema (Respiratory) - Drugs in Development, 2021 Summary Emphysema (Respiratory) - Drugs in Development, 2021 provides an overview of the Emphys...
Published: Apr-2021 | No. of Pages: 45
|
$ 2000 | |
| Tropomyosin Receptor Kinase (TRK or EC 2.7.10.1) - Drugs in Development, 2021
Tropomyosin Receptor Kinase (TRK or EC 2.7.10.1) - Drugs in Development, 2021 Summary Tropomyosin Receptor Kinase (TRK or EC 2.7.10.1) - Drugs in De...
Published: Apr-2021 | No. of Pages: 50
|
$ 3000 | |
| Atrial Natriuretic Peptide Receptor 1 (Atrial Natriuretic Peptide Receptor Type A or Guanylate Cyclase A or NPR1 or EC 4.6.1.2) - Drugs in Development, 2021
Atrial Natriuretic Peptide Receptor 1 (Atrial Natriuretic Peptide Receptor Type A or Guanylate Cyclase A or NPR1 or EC 4.6.1.2) - Drugs in Development...
Published: Apr-2021 | No. of Pages: 45
|
$ 3000 | |
| Hemagglutinin 5 (H5) - Drugs in Development, 2021
Hemagglutinin 5 (H5) - Drugs in Development, 2021 Summary Hemagglutinin 5 (H5) - Drugs in Development, 2021 provides in depth analysis on Hemaggluti...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Propionic Acidemia (Metabolic Disorders) - Drugs in Development, 2021
Propionic Acidemia (Metabolic Disorders) - Drugs in Development, 2021 Summary Propionic Acidemia (Metabolic Disorders) - Drugs in Development, 2021 ...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 | |
| Enterococcus Faecium Infections (Infectious Disease) - Drugs in Development, 2021
Enterococcus Faecium Infections (Infectious Disease) - Drugs in Development, 2021 Summary Enterococcus Faecium Infections (Infectious Disease) - Dru...
Published: Apr-2021 | No. of Pages: 45
|
$ 2000 |